How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

524 results for

Postpartum Endometritis

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

381. Mirena in Idiopathic Menorrhagia

to international guidelines. These woman should also accept to be on contraception during the time period that they have Mirena in situ. Age limit 30-45 BMI= 18-34 Signed informed consent Exclusion Criteria: Medical conditions featured in the Mirena data sheet (See Appendix 1) that contraindicate its use, listed below: Known or suspected pregnancy; current or recurrent pelvic inflammatory disease; infection of the lower genital tract; postpartum endometritis; septic abortion during the past three months

2009 Clinical Trials

382. GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China

: Postpartum insertions should be postponed until uterus is fully involuted, however not earlier than 6 weeks after delivery. If involution is substantially delayed, consider waiting until 12 weeks postpartum. In case of a difficult insertion and/or exceptional pain or bleeding during or after insertion, physical examination and ultrasound should be performed immediately to exclude perforation. History of ectopic pregnancies. Note: For Korea only: History of ectopic pregnancies or high probability (...) of ectopic gestation. Infected abortion within 3 months prior to visit 1. Note: For Korea only: Endometritis after delivery or infected abortion within 3 months prior to visit 1. Abnormal uterine bleeding of unknown origin. Any genital infection (until successfully treated). History of, or current, pelvic inflammatory disease Congenital or acquired uterine anomaly. Any distortion of the uterine cavity (by e.g., fibroids) likely to cause problems (in the opinion of the investigator) during insertion

2009 Clinical Trials

383. Comparison of Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Intrapartum Chorioamnionitis: a Randomized Controlled Trial

success defined as resolution of fever by 24 hours postpartum Secondary Outcome Measures : Composite Maternal Morbidity [ Time Frame: Up to 6 weeks after delivery ] Composite of maternal postpartum morbidity defined as any of the following outcomes: endometritis, clinical sepsis, pneumonia, blood transfusion or ileus. Neonatal Clinical Sepsis (Early Onset) [ Time Frame: Up to 6 weeks after delivery ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate (...) , including routine intrapartum treatment of Group B streptococcus (GBS) colonization using ampicillin. When a participating patient is diagnosed with chorioamnionitis, she will be randomized in a blinded fashion to Arm 1 (Unasyn) or Arm 2 (ampicillin/gentamicin). She will be treated as per standard of care with tylenol, intravenous fluids, and her labor managed per physician discretion. From the time of diagnosis of chorioamnionitis until determination of treatment success or failure in the postpartum

2009 Clinical Trials

384. Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding

three months according to the assessment of the investigator and according to the international and national guidelines. These women should also accept to be on contraception during the time period that they have Mirena in situ Body Mass Index = 18-30 Exclusion Criteria: One or more of the following disorders: Current or recurrent pelvic inflammatory disease; infection of the lower genital tract; postpartum endometritis; septic abortion during the past three months; cervicitis; cervical dysplasia

2009 Clinical Trials

385. Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine

received Methergine 0.2mg po every 6 hours for two days, plus routine postpartum care. Drug: Methergine Scheduled methergine 0.2 mg PO every 6hrs for duration of postpartum stay No Intervention: No treatment No treatment group received only routine postpartum care. Outcome Measures Go to Primary Outcome Measures : Endometritis Incidence [ Time Frame: One year ] Number of participants who developed endometritis Eligibility Criteria Go to Information from the National Library of Medicine Choosing (...) Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine - Full Text View - Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2009 Clinical Trials

386. Iodine

for people with foot ulcers related to diabetes. Inflammation of the uterus (endometritis) . Washing the vagina with a solution containing iodine in the form of povidone-iodine before a Cesarean delivery reduces the risk of the inflammation of the uterus. Painful fibrous breast tissue (fibrocystic breast disease) . Research shows that taking iodine, especially molecular iodine, reduces painful fibrous breast tissue. Breast pain (mastalgia) . Taking 3000-6000 mg of molecular iodine for 5 months seems (...) 0.35% to 10% povidone-iodine has been applied for one to three minutes before or after wound closure. Swelling of the uterine lining (endometritis) : A vaginal wash containing iodine in the form of povidone-iodine 1% to 10% has been used immediately before Cesarean delivery. CHILDREN BY MOUTH : For iodine deficiency : Consumption of iodized salt is recommended in most cases. For most people, iodized salt containing 20-40 mg of iodine per kilogram of salt is recommended. If salt consumption is less

2009 National Centre for Complementary and Alternative Medicine

387. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. (Abstract)

contacted to locate any other studies. The search strategy was iterative.Randomized clinical trials assessing the efficacy and safety of ECS for prevention of MTCT of HIV-1 were included in the analysis, as were observational studies with relevant data.Data regarding HIV-1 infection status of infants born to HIV-1-infected women according to mode of delivery were extracted from the reports of the studies. Similarly, data regarding postpartum morbidity (PPM) (including minor (e.g., febrile morbidity (...) , urinary tract infection) and major (e.g., endometritis, thromboembolism) morbidity) of the HIV-1-infected women, and infant morbidity, according to mode of delivery were extracted.One randomized clinical trial of the efficacy of ECS for prevention of MTCT of HIV-1 was identified. No data regarding infant morbidity according to the HIV-1-infected mother's mode of delivery were available. Data regarding PPM according to mode of delivery were available from this clinical trial as well as from five

2005 Cochrane

388. Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. (Abstract)

Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. Retained placenta is a potentially life-threatening condition because of its association with postpartum haemorrhage. Manual removal of placenta increases the likelihood of bacterial contamination in the uterine cavity.To compare the effectiveness and side-effects of routine antibiotic use for manual removal of placenta in vaginal birth in women who received antibiotic prophylaxis and those who did (...) not and to identify the appropriate regimen of antibiotic prophylaxis for this procedure.We searched the Cochrane Pregnancy and Childbirth Group Trials Register (30 November 2005), CENTRAL (The Cochrane Library, Issue 4, 2005), MEDLINE (from 1966 to January 2005), EMBASE (from 1980 to January 2005), CINAHL (from 1982 to January 2005) and LILACS (from 1982 to January 2005).All randomized controlled trials comparing antibiotic prophylaxis and placebo or non antibiotic use to prevent endometritis after manual

2006 Cochrane

389. Fetal pulse oximetry for fetal assessment in labour. Full Text available with Trip Pro

0.45, 95% CI 0.28 to 0.72). The only reported neonatal seizure occurred in the CTG only group (RR 0.29 95% CI 0.01 to 7.08). Use of FPO with CTG decreased operative delivery (caesarean section, forceps, vacuum) for nonreassuring fetal status (RR 0.71, 95% CI 0.55 to 0.93) compared with CTG alone. No differences were seen for overall operative deliveries, endometritis, intrapartum or postpartum haemorrhage, uterine rupture, low Apgar scores, umbilical arterial pH or base excess, admission

2004 Cochrane

390. Elective Cesarean section to prevent anal incontinence and brachial plexus injuries associated with macrosomia: a decision analysis

crucial to the analysis were brachial plexus injury to the newborn, maternal anal incontinence, maternal urinary incontinence, emergency hysterectomy, blood transfusion due to postpartum haemorrhage, and maternal mortality. The benefits were estimated for two individuals simultaneously (the mother and the baby). Outcomes assessed in the review The outcomes estimated from the literature were the probability estimates associated with specific clinical conditions considered in the model, such as: anal (...) transient conditions (e.g. endometritis or transient tachypnoea of the newborn) were not considered. It was also noted that the model focused on primigravidae and the proposed policy might not be appropriate for women planning large families. Implications of the study The study results supported the proposed policy whereby all primigravidae patients would be offered an ultrasound at 39 weeks' gestation, followed by elective C-section for any estimated foetal weights greater than or equal to 4,500 g

2005 NHS Economic Evaluation Database.

391. Management of bacterial vaginosis

their risk of developing PID subsequently. BV is common in some populations of women undergoing elective termination of pregnancy (TOP), and is associated with post-TOP endometritis and PID (level of evidence Ib)(5). In pregnancy BV is associated with late miscarriage, preterm birth, preterm premature rupture of membranes, and postpartum endometritis (Ib) (6-10). BV has been associated with an increased incidence of vaginal cuff cellulitis and abscess formation following transvaginal hysterectomy (III (...) on the effectiveness of treatment administered at the time of TOP. • These studies support screening for and treating BV with either metronidazole or clindamycin cream, to reduce the incidence of subsequent endometritis and PID (Ia). Sexual partners • No reduction in relapse rate was reported from two studies in which male partners of women with BV were treated with metronidazole, one study of tinidazole, and one of clindamycin(18;37) (Ib). Routine screening and treatment of male partners are therefore

2006 British Association for Sexual Health and HIV

392. Canadian consensus guidelines for the management of pregnant HIV-positive women and their offspring

recommendation] 15. Avoid unnecessary rupture of the membranes. In addi- tion, avoid use of fetal scalp electrodes and fetal scalp sampling. Carefully evaluate the need to use forceps or vacuum, taking into account the entire clinical situation. [Level II D recommendation] Postpartum care of the woman Recommendations 16. Carefully monitor the woman for signs of endometritis or wound infection. [Level III B recommendation] 17. A longer-than-average postpartum hospital stay may be re- quired to ensure (...) women and their care teams in making decisions regarding optimal manage- ment during pregnancy, delivery and the postpartum period. Benefits of implementing guidelines: Optimal prenatal, intra- partum and postpartum care of the woman and her infant will result in significant reduction in perinatal HIV transmission (from about 25% to less than 1% with optimal care), improve pregnancy outcomes, minimize the risk of toxic effects to the fetus/neonate, and improve short-term and long-term health

2003 CPG Infobase

393. Antibiotic prophylaxis for cesarean section. (Abstract)

Antibiotic prophylaxis for cesarean section. The single most important risk factor for postpartum maternal infection is Cesarean delivery.The objective of this review was to assess the effects of prophylactic antibiotic treatment on infectious complications in women undergoing Cesarean delivery.We searched the Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register.Randomised trials comparing antibiotic prophylaxis or no treatment for both elective (...) and non-elective Cesarean section.Two reviewers assessed trial quality and extracted data.Sixty-six trials were included. Use of prophylactic antibiotics in women undergoing Cesarean section substantially reduced the incidence of episodes of fever, endometritis, wound infection, urinary tract infection and serious infection after Cesarean section. The reduction in the risk of endometritis with antibiotics was similar across different patient groups. The relative risk for elective Cesarean section

2000 Cochrane

394. Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour. (Abstract)

arterial pH, oxytocin augmentation, meconium aspiration, neonatal pneumonia or postpartum endometritis. Prophylactic amnioinfusion was associated with increased intrapartum fever (relative risk 3.48, 95% confidence interval 1.21 to 10.05).There appears to be no advantage of prophylactic amnioinfusion over therapeutic amnioinfusion carried out only when fetal heart rate decelerations or thick meconium-staining of the liquor occur.

2000 Cochrane

395. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction

evaluation were PCR tests, 35- to 37-week culture, maternal antibiotic prophylaxis, in-hospital care of non-infected infants, NICU care for GBS-infected infants, and the lifetime health care costs for a healthy or disabled infant. The cost/resource boundary of the study was that of society. The costs of treating the maternal outcomes of postpartum bacteraemia and endometritis were excluded since the analysis focused on infant costs. Resource use was mainly estimated from authors' assumptions and some

2002 NHS Economic Evaluation Database.

396. Cost-effective delivery management of the vertex and nonvertex twin gestation

(including intra-amniotic infection, postpartum endometritis, sepsis, or postpartum haemorrhage), maternal length of stay (days); the neonatal rates of pulmonary disease, neonatal infectious disease, the percentage of infants requiring the use of ventilator, the percentage of infants being admitted to the normal newborn nursery, and neonatal length of hospitalisation. The three study groups were found to be comparable in terms of maternal demographics, medical complications, gestational age, birth weight (...) separately. Cost analysis covered the costs of maternal hospitalisation including the delivery and postpartum course, and neonatal hospitalisation. The perspective adopted in the cost analysis was that of the third-party insurer or public payer. The source of the charge data was the study hospital finance office. Charge data from a single institution were judged to be a good proxy for true costs. The date of the price data was 1996. Charge data were inflated to 1996 constant dollars. The cost analysis

1998 NHS Economic Evaluation Database.

397. Membrane sweeping versus dinoprostone vaginal insert in the management of pregnancies beyond 41 weeks with an unfavourable cervix

. The gestational age on admission, the increase of gestational age from study entrance to admission to labour and delivery, the mode of delivery, the reason for operative delivery, birth weight, Apgar scores, neonatal disposition, and reasons for admission to newborn intensive care unit were similar for both groups. Two patients in the cervidil group and one in the membrane-sweeping group developed postpartum endometritis. All three patients had undergone abdominal delivery, had prolonged rupture of membranes

1999 NHS Economic Evaluation Database.

398. A randomized, prospective study comparing once-daily gentamicin versus thrice-daily gentamicin in the treatment of puerperal infection

intravenously every 24 hours with clindamycin 1,200 mg intravenously every 12 hours. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients with puerperal endometritis or with chorioamnionitis in labour. The patients met the following criteria: two temperatures of 100.4 degree F or higher 6 hours apart excluding the first 12 postpartum hours, a single temperature of 102 degree F or higher in the first 12 postpartum hours, a diagnosis of chorioamnionitis (...) in labour thought to require postpartum prophylactic antibiotic therapy, or a diagnosis of postpartum endometritis after initial discharge from hospital. Additional supporting factors for the diagnosis of postpartum endometritis were uterine tenderness, foul-smelling lochia, an elevated white blood cell count, and maternal tachycardia. Patients were excluded if they had a baseline serum creatinine level greater than 1.5 mg/dl, extrapelvic sources of infection, and allergy or hypersensitivity to either

1997 NHS Economic Evaluation Database.

399. Prophylactic amnioinfusion for intrapartum oligohydramnios: a meta-analysis of randomized controlled trials

rate for foetal heart rate abnormalities, including intrapartum variable decelerations. Secondary outcomes were overall Caesarean section rate, foetal acidaemia at birth, foetal heart rate abnormalities during labour, Apgar scores under 7 at 5 minutes, and postpartum endometritis. Only studies with clearly documented outcome data were eligible. Acidaemia at birth was defined as an umbilical artery pH of less than 7.20 (most studies) or less than 7.10 (two studies). How were decisions (...) section rate, foetal acidaemia at birth, foetal heart rate abnormalities during labour, and Apgar scores under 7 at 5 minutes. Postpartum endometritis rates were similar among treatment groups. Apart from acidaemia at birth, studies were homogeneous for outcomes. For most outcomes, funnel plots showed no evidence of publication bias. The included studies were of high quality. Caesarean section rate for foetal heart rate abnormalities (12 RCTs with 1,240 women): OR 0.23 (95% CI: 0.15, 0.35

2000 DARE.

400. Intrapartum amnioinfusion for meconium-stained fluid: meta-analysis of prospective clinical trials

of women randomly assigned to amnioinfusion groups ranged from 17 to 323, with control groups generally of a similar size (18 to 329). Outcomes assessed in the review Meconium below the vocal chords, meconium aspiration syndrome, foetal acidaemia (umbilical artery pH below 7.20), Caesarean delivery, and postpartum endometritis. How were decisions on the relevance of primary studies made? All of the trials were reviewed independently by the investigators. It was not reported how many investigators (...) ) without increased postpartum endometritis (OR 0.47, 95% CI: 0.31, 0.72). There were several reports of adverse events associated with amnioinfusion. It increased basal uterine tone even when a small volume (250 mL) of infusate was used. Uterine hypertonus and foetal bradycardia have been associated with specific infusion protocols, although they seem to be eliminated by adjustment of the infusion rate. Statistically significant heterogeneity was found for the outcomes of frequency of meconium

2000 DARE.

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>